General Information of the Compound
| Compound ID |
CP0455080
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(1,1-dioxo-1,2-thiazolidin-2-yl)-5-ethoxy-N-[(2S,3R)-3-hydroxy-1-phenyl-4-({[3-(trifluoromethyl)phenyl]methyl}amino)butan-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H34F3N3O5S
|
||||||||||||||||||
| Molecular Weight |
605.679
|
||||||||||||||||||
| Canonical SMILES |
CCOc1cc(cc(c1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)CNCc1cccc(c1)C(F)(F)F)N1CCCS1(=O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H34F3N3O5S/c1-2-41-26-17-23(16-25(18-26)36-12-7-13-42(36,39)40)29(38)35-27(15-21-8-4-3-5-9-21)28(37)20-34-19-22-10-6-11-24(14-22)30(31,32)33/h3-6,8-11,14,16-18,27-28,34,37H,2,7,12-13,15,19-20H2,1H3,(H,35,38)/t27-,28+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QCGIDYZRRCDEKC-WUFINQPMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01020, Beta-secretase 1
Protein ID: PT01134, Beta-secretase 2
Protein ID: PT01625, Cathepsin D